Sarcomas are rare, heterogeneous tumours affecting patients of any age. Previous surveys describe that sarcoma patients report a significantly worse experience than those with common cancers. Consequently, Sarcoma UK conducted a national survey and these data were examined for age- and tumour-related differences in patients’ experiences. Patients were randomly selected from respondents to National Cancer Patient Experience Surveys (n = 900). Differences between patient groups according to age (Adolescents and Young Adults [AYA] 18–39 years, middle-aged 40–64 years, elderly 65 + years) and tumour type (soft-tissue [STS] vs. bone]) were analysed with t-tests or chi-square tests. Survey response rate was 62% (n = 558; STS 75%, bone sarcoma 25%). Delay in diagnosis was reported; 27% patients (n = 150) waited > 3 months and initial symptoms were incorrectly interpreted; AYA STS patients were significantly more likely to be treated for another condition, or advised that their symptoms were not serious, than older STS patients. Clinical trial participation was low (6%, n = 35). Symptom burden was high, most commonly daytime fatigue (48%, n = 277) and pain (44%, n = 248). AYAs were significantly more likely to report most side-effects and post-treatment concerns than older patients. Elderly patients were more satisfied with the information and emotional support provided than younger patients, however were significantly less likely to be referred to rehabilitation services. This study identifies significant age-related differences in the sarcoma patient journey, which are not only related to variation in tumour-types. These results provide rationale for adopting an age-specific approach to the management of sarcoma patients in order to improve overall patient experience.
Purpose
Diagnostic delay in soft tissue tumors: a single-center study of a university cancer center with a focus on health services research, BMC Health Services Research
PDF) Changes in Health-Related Quality of Life Following Surgery in Patients with High-Grade Extremity Soft-Tissue Sarcoma: A Prospective Longitudinal Study
Reducing Cancer Risk AACR Cancer Progress Report 2023
Cancers, Free Full-Text
Beyond Teenage and Young Adult Cancer Care: Care Experiences of Patients Aged 25–39 Years Old in the UK National Health Service - ScienceDirect
Current Oncology, Free Full-Text
COVID-19 and Cancer Comorbidity: Therapeutic Opportunities and
The route to diagnosis of sarcoma patients: Results from an
Soft tissue sarcoma: Recognizing a rare disease
Clear Cell Sarcoma of the Kidney: Practice Essentials, Background
Cancers, Free Full-Text
Sarcoma Awareness Month Announcement
Pesticide-Induced Diseases: Cancer — Beyond Pesticides